Midatech Divests US Unit To Focus On Its Rival Drug To Novartis' Sandostatin LAR

 
• By Sten Stovall
  
R&D
UK Biotech Selling US Affiliate To Raise Money For Pipeline Advancement • Source: Shutterstock

More from Strategy

More from Business